502 related articles for article (PubMed ID: 31148183)
41. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.
Qiu L; Huang Y; Li Z; Dong X; Chen G; Xu H; Zeng Y; Cai Z; Liu X; Liu J
Mol Oncol; 2019 Feb; 13(2):441-455. PubMed ID: 30537115
[TBL] [Abstract][Full Text] [Related]
42. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
43. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
Cao S; Wang G; Wang J; Li C; Zhang L
Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
[TBL] [Abstract][Full Text] [Related]
44. MafF Is Regulated via the circ-ITCH/miR-224-5p Axis and Acts as a Tumor Suppressor in Hepatocellular Carcinoma.
Wu M; Deng X; Zhong Y; Hu L; Zhang X; Liang Y; Li X; Ye X
Oncol Res; 2020 May; 28(3):299-309. PubMed ID: 31969212
[TBL] [Abstract][Full Text] [Related]
45. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
46. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression.
Chen W; Quan Y; Fan S; Wang H; Liang J; Huang L; Chen L; Liu Q; He P; Ye Y
Cancer Lett; 2020 Apr; 475():119-128. PubMed ID: 32014458
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis.
Zhan W; Liao X; Chen Z; Li L; Tian T; Yu L; Wang W; Hu Q
J Cell Physiol; 2020 Feb; 235(2):1733-1745. PubMed ID: 31317555
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
49. Circulating RNAs, circ_4911 and circ_4302, are novel regulators of endothelial cell function under a hepatocellular carcinoma microenvironment.
Yan K; Cheng W; Xu X; Cao G; Ji Z; Li Y
Oncol Rep; 2020 Oct; 44(4):1727-1735. PubMed ID: 32700752
[TBL] [Abstract][Full Text] [Related]
50. Hsa_circ_0011946 promotes the migration and invasion of hepatocellular carcinoma by inducing EMT process.
Ren L; Zhai H; Wang XL; Li JZ; Xia YH
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1108-1115. PubMed ID: 32096173
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis.
Zhang X; Qiu S; Luo P; Zhou H; Jing W; Liang C; Tu J
Cancer Biomark; 2018; 22(1):135-142. PubMed ID: 29630526
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.
Tian F; Yu C; Wu M; Wu X; Wan L; Zhu X
Cell Prolif; 2019 Sep; 52(5):e12635. PubMed ID: 31334580
[TBL] [Abstract][Full Text] [Related]
53. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.
Shi L; Yan P; Liang Y; Sun Y; Shen J; Zhou S; Lin H; Liang X; Cai X
Cell Death Dis; 2017 Nov; 8(11):e3171. PubMed ID: 29144509
[TBL] [Abstract][Full Text] [Related]
54. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
Zhang PF; Wei CY; Huang XY; Peng R; Yang X; Lu JC; Zhang C; Gao C; Cai JB; Gao PT; Gao DM; Shi GM; Ke AW; Fan J
Mol Cancer; 2019 Jun; 18(1):105. PubMed ID: 31153371
[TBL] [Abstract][Full Text] [Related]
55. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
56. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
[TBL] [Abstract][Full Text] [Related]
57. Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression
Su Y; Xu C; Liu Y; Hu Y; Wu H
Aging (Albany NY); 2019 May; 11(10):3362-3375. PubMed ID: 31137016
[TBL] [Abstract][Full Text] [Related]
58. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
[TBL] [Abstract][Full Text] [Related]
59. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
60. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
